We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Nutrient Levels Alter Transplant Outcome

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00560014
First Posted: November 19, 2007
Last Update Posted: November 19, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Institutes of Health (NIH)
Information provided by:
University of Cincinnati
  Purpose
The purpose of this study is to look at lipid profiles of plasma and RBC and amino acid profiles in plasma to determine if they are associated with allograft rejection, calcineurin inhibitor toxicity or new onset diabetes mellitus in renal transplant patients receiving dietary supplements with arginine and omega-3 fatty acids.

Condition Intervention
Chronic Renal Disease Dietary Supplement: Arginine and canola oil Dietary Supplement: Coromega and Arginine

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Official Title: Role of Immunonutrient Levels in Preventing Complications After Renal Transplantation

Resource links provided by NLM:


Further study details as provided by University of Cincinnati:

Primary Outcome Measures:
  • Plasma and red blood cell lipid profiles [ Time Frame: Within 1 year ]
  • Plasma amino acid profiles [ Time Frame: within 1 year ]

Enrollment: 54
Study Start Date: September 1997
Study Completion Date: May 2005
Arms Assigned Interventions
Experimental: 1
Arginine and Canola oil supplemented group
Dietary Supplement: Arginine and canola oil
Canola oil 1 tablespoon BID Arginine 9.0grams BID
Other Name: Arginaid
Experimental: 2
Arginine and Coromega
Dietary Supplement: Coromega and Arginine
Arginine 9.0 grams BID Coromega dose based on weight
Other Name: Arginaide
No Intervention: 3
Control

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Renal transplant recipient
  • Appropriate blood samples drawn and analyzed
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00560014


Locations
United States, District of Columbia
Washington Hospital
Washington, District of Columbia, United States, 20010
United States, North Carolina
Duke University School Of Medicine
Durham, North Carolina, United States, 27710
Sponsors and Collaborators
University of Cincinnati
National Institutes of Health (NIH)
Investigators
Principal Investigator: J. W. Alexander, M.D. UC Surgeons Center fo Surgical Weight Loss/ University of Cincinnati
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00560014     History of Changes
Other Study ID Numbers: LIPIDS
R03 AI142743
5U01AI040167 ( U.S. NIH Grant/Contract )
First Submitted: November 14, 2007
First Posted: November 19, 2007
Last Update Posted: November 19, 2007
Last Verified: October 2007

Additional relevant MeSH terms:
Renal Insufficiency, Chronic
Kidney Failure, Chronic
Renal Insufficiency
Kidney Diseases
Urologic Diseases